Global Atazanavir Market Research Report 2019
Table of Contents
Executive Summary
1 Atazanavir Market Overview
- 1.1 Product Overview and Scope of Atazanavir
- 1.2 Atazanavir Segment by Type
- 1.2.1 Global Atazanavir Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 150 mg capsule
- 1.2.3 200 mg capsule
- 1.2.4 300 mg capsule
- 1.2.5 50 mg oral powder packet
- 1.3 Atazanavir Segment by Application
- 1.3.1 Atazanavir Consumption Comparison by Application (2014-2025)
- 1.3.2 Adults
- 1.3.3 Children 3 months of age and older
- 1.4 Global Atazanavir Market by Region
- 1.4.1 Global Atazanavir Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Atazanavir Market Size
- 1.5.1 Global Atazanavir Revenue (2014-2025)
- 1.5.2 Global Atazanavir Production (2014-2025)
2 Global Atazanavir Market Competition by Manufacturers
- 2.1 Global Atazanavir Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Atazanavir Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Atazanavir Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Atazanavir Production Sites, Area Served, Product Types
- 2.5 Atazanavir Market Competitive Situation and Trends
- 2.5.1 Atazanavir Market Concentration Rate
- 2.5.2 Atazanavir Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Atazanavir Production Market Share by Regions
- 3.1 Global Atazanavir Production Market Share by Regions
- 3.2 Global Atazanavir Revenue Market Share by Regions (2014-2019)
- 3.3 Global Atazanavir Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Atazanavir Production
- 3.4.1 North America Atazanavir Production Growth Rate (2014-2019)
- 3.4.2 North America Atazanavir Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Atazanavir Production
- 3.5.1 Europe Atazanavir Production Growth Rate (2014-2019)
- 3.5.2 Europe Atazanavir Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Atazanavir Production (2014-2019)
- 3.6.1 China Atazanavir Production Growth Rate (2014-2019)
- 3.6.2 China Atazanavir Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Atazanavir Production (2014-2019)
- 3.7.1 Japan Atazanavir Production Growth Rate (2014-2019)
- 3.7.2 Japan Atazanavir Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Atazanavir Consumption by Regions
- 4.1 Global Atazanavir Consumption by Regions
- 4.2 North America Atazanavir Consumption (2014-2019)
- 4.3 Europe Atazanavir Consumption (2014-2019)
- 4.4 China Atazanavir Consumption (2014-2019)
- 4.5 Japan Atazanavir Consumption (2014-2019)
5 Global Atazanavir Production, Revenue, Price Trend by Type
- 5.1 Global Atazanavir Production Market Share by Type (2014-2019)
- 5.2 Global Atazanavir Revenue Market Share by Type (2014-2019)
- 5.3 Global Atazanavir Price by Type (2014-2019)
- 5.4 Global Atazanavir Production Growth by Type (2014-2019)
6 Global Atazanavir Market Analysis by Applications
- 6.1 Global Atazanavir Consumption Market Share by Application (2014-2019)
- 6.2 Global Atazanavir Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Atazanavir Business
- 7.1 Bristol-Myers Squibb
- 7.1.1 Bristol-Myers Squibb Atazanavir Production Sites and Area Served
- 7.1.2 Atazanavir Product Introduction, Application and Specification
- 7.1.3 Bristol-Myers Squibb Atazanavir Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 TEVA
- 7.2.1 TEVA Atazanavir Production Sites and Area Served
- 7.2.2 Atazanavir Product Introduction, Application and Specification
- 7.2.3 TEVA Atazanavir Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Cipla
- 7.3.1 Cipla Atazanavir Production Sites and Area Served
- 7.3.2 Atazanavir Product Introduction, Application and Specification
- 7.3.3 Cipla Atazanavir Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Mylan
- 7.4.1 Mylan Atazanavir Production Sites and Area Served
- 7.4.2 Atazanavir Product Introduction, Application and Specification
- 7.4.3 Mylan Atazanavir Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Aurobindo Pharma
- 7.5.1 Aurobindo Pharma Atazanavir Production Sites and Area Served
- 7.5.2 Atazanavir Product Introduction, Application and Specification
- 7.5.3 Aurobindo Pharma Atazanavir Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Emcure
- 7.6.1 Emcure Atazanavir Production Sites and Area Served
- 7.6.2 Atazanavir Product Introduction, Application and Specification
- 7.6.3 Emcure Atazanavir Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
8 Atazanavir Manufacturing Cost Analysis
- 8.1 Atazanavir Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Atazanavir
- 8.4 Atazanavir Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Atazanavir Distributors List
- 9.3 Atazanavir Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Atazanavir Market Forecast
- 11.1 Global Atazanavir Production, Revenue Forecast
- 11.1.1 Global Atazanavir Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Atazanavir Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Atazanavir Price and Trend Forecast (2019-2025)
- 11.2 Global Atazanavir Production Forecast by Regions (2019-2025)
- 11.2.1 North America Atazanavir Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Atazanavir Production, Revenue Forecast (2019-2025)
- 11.2.3 China Atazanavir Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Atazanavir Production, Revenue Forecast (2019-2025)
- 11.3 Global Atazanavir Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Atazanavir Consumption Forecast (2019-2025)
- 11.3.2 Europe Atazanavir Consumption Forecast (2019-2025)
- 11.3.3 China Atazanavir Consumption Forecast (2019-2025)
- 11.3.4 Japan Atazanavir Consumption Forecast (2019-2025)
- 11.4 Global Atazanavir Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Atazanavir Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is taken by mouth once a day.
The global Atazanavir market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Atazanavir volume and value at global level, regional level and company level. From a global perspective, this report represents overall Atazanavir market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Bristol-Myers Squibb
TEVA
Cipla
Mylan
Aurobindo Pharma
Emcure
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
150 mg capsule
200 mg capsule
300 mg capsule
50 mg oral powder packet
Segment by Application
Adults
Children 3 months of age and older